Skip to main content
Subscribe
Register
Sign in
Membership
Insights
Events
About
Subscribe
Register
Sign in
Pharmaceuticals
Latest Articles
Deutsche Bank Looks to Jason Haas to Build Health Care Franchise
David Rothnie
Disease Charities: The New Financiers of Drug Development
Udayan Gupta
Fosun’s Liang Xinjun Targets Middle-Class Consumers
Allen T Cheng
Gilead Sciences’ Miracle Drug Combination
Vitaliy Katsenelson
GlaxoSmithKline’s Andrew Witty: On a Mission
Neil Sen
Health Care: Pharmaceuticals/Major 2010 First
Joshua Pasanisi
Health Care: Pharmaceuticals/Specialty
Health Care: Pharmaceuticals/Specialty 2010 First
Joshua Pasanisi
Healthcare Uncertainty Opens Window for ETF Investors
Maureen Nevin Duffy
Hedge Fund Manager Kyle Bass Declares War on Drug Prices
Jess Delaney
Interview with Jürgen Dormann: Will Aventis Sell the Farm?
David Lanchner
Is This The Future Of Big Pharma?
Fran Hawthorne
Life Sciences Financing Goes Global, Possibly to the Detriment of U.S. Companies
Udayan Gupta
Mike Pearson’s New Prescription for the Pharmaceuticals Industry
Michael Peltz
MIT’s Andrew Lo Touts Megafund to Tackle Cancer, Rare Diseases
Kaitlin Ugolik
Novartis CEO Joseph Jimenez Pushes Drug Discovery
Julie Segal
Pharmaceutical Companies Gird for Drug-Price Reckoning
Kaitlin Ugolik
Riding Out Wild Equity Markets
Kent Hargis
,
Sammy Suzuki
,
Chris Marx
More Articles